Ferrous Ascorbate, Folic Acid & Zinc Sulphate Softgel Capsules

₹ 950/Box

Packaging Size10x10
Manufacturer NameMITS Healthcare Private
FormCapsules
CompositionFerrous Ascorbate, Folic Acid & Zinc Sulphate
Prescription/Non prescriptionPrescription
BrandIROMITS-SG
Packaging TypeBlister
AvailabilityIn Stock
Brand Name : IROMITS-SG
Composition : Ferrous ascorbate 100mg,Folic Acid 1.5mg,Zinc Sulphate 22.5mg
Pkg: 10x10
Mrp : 950.00

It is an oral iron,folic acid and zinc preparation indicated for the treatment of iron,folic acid and zinc deficiancy.

INDICATION:
It is indicated on prophylaxis of iron deficiancy especially when inadequate diet cells for supplementary zinc and iron during pregnancy and anemia

Exports To: Bangladesh | Nepal | Ethiopia | United States Of America | Yemen

Find products similar to Ferrous Ascorbate, Folic Acid & Zinc Sulphate Softgel Capsules

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromPanchkula
ShippingAs per delivery location

Interested in this product?Get Latest Price from the seller

About the Company

GST Registration Date
03-02-2020
Legal Status of Firm
Limited Company
Nature of Business
Manufacturer
Number of Employees
Upto 10 People
Annual Turnover
5 - 25 Cr
IndiaMART Member Since
Aug 2011
GST
06AAGCM6143B1ZU
Import Export Code (IEC)
AAGCM*****
Exports to
Bangladesh | Nepal | Ethiopia | United States Of America | Yemen
Established in The Year 2010, “MITS Healthcare Private Limited'’ Is a Distinguished Manufacturer and Exporter Offering an Enormous Consignment Of Sodium Carboxymethyl-Cellulose Opthalamic Solution, etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.
For our accomplishment story, we are grateful to our Mr .MK Bhatia backing and direction have been useful to us for attaining exponential development in the current market.